Yahoo
BSE - Delayed Quote INR

Evoq Remedies Limited (EVOQ.BO)

1.6000 +0.0400 (+2.56%)
At close: November 9 at 3:23:05 PM GMT+5:30
View in AlphaSpace Currency in INR All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
3/31/2026
3/31/2025
3/31/2024
3/31/2023
Total Revenue
255,068 255,068 117,567 40,525 203,899
Cost of Revenue
-254,750 -254,750 -130,815 -15,573 -193,280
Gross Profit
318 318 -13,248 24,952 10,619
Selling, General and Administrative Expenses
-689 -689 -682 -38,545 -45,172
Operation and Maintenance Expenses
-27 -- -27 -83 0
Depreciation, Amortization and Depletion
-511 -511 -489 -73 -39
Taxes Other Than Income Taxes
-- -- -- -- 0
Other Income/Expense, Operating
-14,129 -14,129 -8,445 -2,121 -2,777
Operating Income/Expenses
-15,329 -15,329 -9,616 -40,822 -47,988
Total Operating Profit/Loss
-15,011 -15,011 -22,864 -15,870 -37,369
Total Net Finance Income/Expense
0 0 0 -1 -13
Irregular Income/Expenses
0 0 0 -580 0
Other Income/Expense, Non-Operating
12,501 12,501 24,146 22,565 60,227
Non-Operating Income/Expenses, Total
12,501 12,501 24,146 21,984 60,214
Pretax Income
-2,510 -2,510 1,282 6,114 22,845
Provision for Income Tax
111 111 -400 -1,590 -6,652
Net Income from Continuing Operations
-2,399 -2,399 882 4,524 16,193
Discontinued Operations
0 0 0 -- --
Net Income after Extraordinary Items and Discontinued Operations
-2,399 -2,399 882 4,524 16,193
Net Income after Non-Controlling/Minority Interests
-2,399 -2,399 882 4,524 16,193
Net Income Available to Common Stockholders
-2,399 -2,399 882 4,524 16,193
Diluted Net Income Available to Common Stockholders
-2,399 -2,399 882 4,524 16,193
Basic EPS
-0.10 -0.10 0.06 0.33 1.19
Diluted EPS
-0.10 -0.10 0.06 0.33 1.19
Basic Weighted Average Shares Outstanding
23,990 23,990 24,990.7690 13,709.0910 13,607.5630
Diluted Weighted Average Shares Outstanding
23,990 23,990 24,990.7690 13,709.0910 13,607.5630
Income Statement, Supplemental
EBIT
-2,510 -2,510 1,282 6,114 22,845
EBITDA
-1,999 -1,999 1,771 6,187 22,884
Normalized EBITDA
-1,999 -1,999 1,771 6,767 22,884
3/31/2023 - 3/30/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: